The Wegovy makers’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.

During clinical trials, it became apparent that patients were experiencing significant weight loss. This discovery has led to ...

Learn about GLP-1 medications, their benefits, risks, and who should (or shouldn’t) consider using them. Due to its rise in ...

SINGAPORE – Newer drugs within a class originally developed to treat diabetes are now gaining attention as potential ...